Use of doravirine-based regimens in clinical practice in Europe
Our results show high levels of efficacy and low levels of side effects in DOR-containing regimens in both treatment-naive and treatment-experienced PWH.
Authors
- Laura Levi (ORCID: https://orcid.org/0000-0002-7421-3450)
- Tetiana Melnyk
- Julie Fox (ORCID: https://orcid.org/0000-0002-0583-8019)
- Jean‐Michel Molina (ORCID: https://orcid.org/0000-0001-8684-2214)
- Anton Pozniak (ORCID: https://orcid.org/0000-0002-4091-5323)
- Karine Lacombe (ORCID: https://orcid.org/0000-0001-8772-9029)
- Debbie Roberts (ORCID: https://orcid.org/0000-0002-7134-3014)
- Lambert Assoumou (ORCID: https://orcid.org/0000-0002-5547-1796)
- Roya Movahedi
- François Raffi
- Agathe Rami
- Carl Fletcher
Institutions
- Inserm (FR)
- King's College - North Carolina (US)
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Université Paris Cité (FR)
- Sorbonne Université (FR)
- London School of Hygiene & Tropical Medicine (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Saint-Antoine (FR)
- Hôpital Lariboisière (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Chelsea and Westminster Hospital (GB)
- Hôpital Saint-Louis (FR)
- Nantes Université (FR)
Publication Details
- Journal
- AIDS
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1097/qad.0000000000004151
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00